Berlin - Delayed Quote EUR
Immunocore Holdings PLC (6YG.BE)
26.40
-0.60
(-2.22%)
As of 8:23:35 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
310,202
310,202
249,428
174,361
36,484
Cost of Revenue
2,731
2,731
1,037
1,089
--
Gross Profit
307,471
307,471
248,391
173,272
36,484
Operating Expense
377,932
377,932
308,040
224,980
211,071
Operating Income
-70,461
-70,461
-59,649
-51,708
-174,587
Net Non Operating Interest Income Expense
6,774
6,774
12,832
-1,653
-5,508
Other Income Expense
10,750
10,750
-14,073
12,478
216
Pretax Income
-52,937
-52,937
-60,890
-40,883
-179,879
Tax Provision
-1,850
-1,850
-5,603
11,660
150
Net Income Common Stockholders
-51,087
-51,087
-55,287
-52,543
-180,029
Diluted NI Available to Com Stockholders
-51,087
-51,087
-55,287
-52,543
-180,029
Basic EPS
-0.95
-1.02
-1.13
-1.09
-4.05
Diluted EPS
-0.95
-1.02
-1.13
-1.09
-4.05
Basic Average Shares
49,863.63
49,991.06
48,888.98
45,804.44
43,862.85
Diluted Average Shares
49,863.63
49,991.06
48,888.98
45,804.44
43,862.85
Total Operating Income as Reported
-70,461
-70,461
-59,649
-51,708
-174,587
Total Expenses
380,663
380,663
309,077
226,069
211,071
Net Income from Continuing & Discontinued Operation
-51,087
-51,087
-55,287
-52,543
-180,029
Normalized Income
-47,763.13
-47,763.13
-43,323.19
-62,665.26
-180,317.71
Interest Income
25,618
25,618
17,986
3,756
65
Interest Expense
18,844
18,844
5,154
5,409
5,573
Net Interest Income
6,774
6,774
12,832
-1,653
-5,508
EBIT
-34,093
-34,093
-55,736
-35,474
-174,306
EBITDA
-29,889
-29,889
-51,646
-30,139
-166,715
Reconciled Cost of Revenue
2,731
2,731
1,037
1,089
--
Reconciled Depreciation
4,204
4,204
4,090
5,335
7,591
Net Income from Continuing Operation Net Minority Interest
-51,087
-51,087
-55,287
-52,543
-180,029
Total Unusual Items Excluding Goodwill
-3,448
-3,448
-13,176
14,157
289
Total Unusual Items
-3,448
-3,448
-13,176
14,157
289
Normalized EBITDA
-26,441
-26,441
-38,470
-44,296
-167,004
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-124.13
-124.13
-1,212.19
4,034.75
0.29
12/31/2021 - 2/16/2023
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade